A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pulmonary Arterial Hypertension
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04503733
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Hua Yao Guangdong Provincial People's Hospital Principal Investigator: Lan Wang Shanghai Pulmonary Hospital, Shanghai, China Principal Investigator: Wei Huang First Affiliated Hospital of Chongqing Medical University Principal Investigator: Zaixin Yu Xiangya Hospital of Central South University Principal Investigator: Fenling Fan First Affiliated Hospital Xi'an Jiaotong University Principal Investigator: Zhicheng Jing Peking Union Medical College Hospital - Dongcheng District Principal Investigator: Jimmy Shaun Smith The Ohio State University - Dorothy M. Davis Heart and Lung Research Institute Principal Investigator: Aaron Waxman Brigham and Women's Hospital Principal Investigator: Kelly Chin University of Texas Southwestern Medical Center Principal Investigator: Ronald Oudiz Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Get Well Soon